Aevice Health

Aevice Health is a company that specializes in developing remote respiratory monitoring solutions. Its flagship device, the AeviceMD Monitoring System, has received approval from the Health Sciences Authority of Singapore (HSA) and is designed for use in patients aged three years and above. The AeviceMD Monitoring System includes a wearable stethoscope capable of detecting abnormal breath sounds and monitoring vital signs, making it suitable for both clinical and home settings. This system continuously monitors digital biomarkers to provide healthcare professionals with an overview of a patient’s lung health. Aevice Health aims to drive medical innovations that transform healthcare, improve outcomes, and empower lives through its non-invasive wearable devices, which enable the early detection of cardiopulmonary abnormalities remotely and in real-time. The company has received ISO 13485:2016 certification for Medical Device and Quality Management Systems and has raised S$2.8M in Pre-Series A funding to expand its solutions into Japan. Aevice Health has partnered with Toho Holdings to develop and commercialize the AeviceMD in Japan and has collaborated with the National University Health System (NUHS) to launch a study for detecting lung sound abnormalities in pediatric patients. Additionally, Aevice Health offers the AireSone Junior, a smart wearable for kids that tracks respiratory and heart rates during sleep, providing parents with a comprehensive overview of their child’s well-being. The company has been selected for the Sunway iLabs Pre-Accelerator Programme and has announced a collaboration with Jiva.ai to develop an AI for asthma exacerbation prediction based on its FDA-cleared remote patient monitor.